{
    "nctId": "NCT05429814",
    "briefTitle": "Topical Menthol Application in Chemotherapy-Related Peripheral Neuropathy in Patients With Breast Cancer",
    "officialTitle": "Topical Menthol Application in Chemotherapy-Related Peripheral Neuropathy in Patients With Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Peripheral Neuropathies, Chemotherapy Effect",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (CIPNAT)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who received at least two cycles of chemotherapy\n* Patients aged 18 and over\n* Women who received the paclitaxel chemotherapy protocol will be included.\n\nExclusion Criteria:\n\n* Those with open wounds and edema on their hands and feet\n* Patients with diabetes mellitus and peripheral neuropathy due to autoimmune disease\n* Use complementary and alternative treatment methods to prevent peripheral neuropathy throughout the treatment process.\n* Those who are allergic to topical menthol to be used in the study will be excluded from the study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}